Tashkent, Uzbekistan (UzDaily.com) -- Implementation of the latest advances for early diagnosis of diseases, including cancer, plays a critical role. This topic was discussed during negotiations between the National Chamber of Innovative Healthcare of Uzbekistan and the international company Roche Diagnostics.

Founded in 1896, the company today is one of the leaders in the field of in vitro diagnostics and histological diagnostics of oncological diseases.

As Regional Director for Central Asia and the Caucasus Hasan Demirchi noted during a meeting in Tashkent on 20 April 2021, throughout its history, the company continues to seek new opportunities for the prevention, diagnosis and treatment of diseases.

“The National Chamber is open to cooperation aimed at improving the country’s health care,” stressed the chairman of this state structure, Rovshan Izamov. “In addition to the implementation of joint projects for the development of highly effective in vitro diagnostics in Uzbekistan, I consider it very important to improve the qualifications of domestic specialists.”

The parties discussed the possibilities of highly efficient technologies in diagnostics, including their impact on reducing the growing costs of health care. Chronic diseases, as well as a growing proportion of the aging population, play a large role in the rise in the cost of the health care system. Experience has shown that in vitro diagnostics, which helps to identify the disease at an early stage, has an effect on improving treatment outcomes and, therefore, on reducing costs.

A specific example is the Alzheimer’s biomarker test, the results of which can exclude the patient’s exposure to radiation that is not indicated for him. That is, in vitro diagnostics can help avoid unnecessary hospitalization of a patient, procedures that are not effective for him, treatment that will not give results. For example, antibiotic susceptibility testing is very popular.

During the negotiations, the parties reached an agreement on further development of cooperation in such areas as new methods of diagnostics of diseases, including molecular diagnostics of HIV and tuberculosis, as well as optimization of laboratory infrastructure.